The task nspx chose was to cure or at least aid in the survival of liver and other horrid cancers! To think that this would be a slam dunk is to be naive. The stock has always been a real gamble with a high risk. Invest your money accordingly with your tolerance. All the company has now is some patents and IP ... how much they are worth remains to be seen!